Register

Innovations and Opportunities with Dexcom Real-Time API and Connected Systems

A Dexcom presentation theater held in conjunction with Diabetes Technology Meeting (DTM).

Wednesday, November 3, 2021
10:00 AM – 11:00 AM PT / 1:00 PM – 2:00 PM ET

Matt Vogel
Senior Director Marketing, Strategic Partnerships, Dexcom

Nate Ahuna
Associate Director of Global Business Development and Strategic Partnerships, Garmin

Dr. Anand K. Iyer
Chief Strategy Officer, Welldoc

November 3-Registration

First Name *

Last Name *

Institution/Company *

Title *

Role *

Country *

Work Zip Code

Email *

I understand that personal information will be collected for use during the registration process and may be shared with our trusted vendors contracted to help facilitate this meeting. Please see Unbridled's Privacy Policy for more information on our commitment to data protection. For questions on privacy or data collection, contact us at [email protected]. *

reCAPTCHA

If you are human, leave this field blank.

BRIEF SAFETY STATEMENT

Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the G6 do not match symptoms or expectations or you’re taking over the recommended maximum dosage amount of 1000mg of acetaminophen every 6 hours, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.